Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seung Hwan Han

Showing results (191-200 of 222) with videos related to

Pageof 23
Sort By:
Clinical Hypertension|December 1, 2022
A randomized, double-blind, multicenter, phase III study on the efficacy and safety of a combination treatment involving fimasartan, amlodipine, rosuvastatin in patients with essential hypertension and dyslipidemia who fail to respond adequately to fimasartan monotherapyEun-Seok Jeon, Sang Wook Lim, Seok-Yeon Kim, et al.
Plos One|April 2, 2021
Smoking may be more harmful to vasospastic angina patients who take antiplatelet agents due to the interaction: Results of Korean prospective multi-center cohortSeong-Sik Cho, Sang-Ho Jo, Hyun-Jin Kim, et al.
Circulation. Cardiovascular Interventions|March 31, 2025
Short-Term DAPT After Complex PCI With Third-Generation DES: A Post Hoc Analysis of the HOST-IDEA TrialJung-Kyu Han, Keehwan Lee, Sang-Hyeon Park, et al.
Journal of the American Heart Association|March 29, 2022
Prognostic Impact of Chronic Vasodilator Therapy in Patients With Vasospastic AnginaYongwhan Lim, Min Chul Kim, Youngkeun Ahn, et al.
Journal of the American College of Cardiology|January 28, 2022
Clinical Outcomes in Patients With Delayed Hospitalization for Non-ST-Segment Elevation Myocardial InfarctionJung-Joon Cha, SungA Bae, Duk-Woo Park, et al.
Circulation|March 5, 2023
Comparison of 3- to 6-Month Versus 12-Month Dual Antiplatelet Therapy After Coronary Intervention Using the Contemporary Drug-Eluting Stents With Ultrathin Struts: The HOST-IDEA Randomized Clinical TrialJung-Kyu Han, Doyeon Hwang, Seokhun Yang, et al.
The American Journal of Cardiology|December 27, 2011
Relation of ruptured plaque culprit lesion phenotype and outcomes in patients with ST elevation acute myocardial infarctionSang Wook Kim, Young Joon Hong, Gary S Mintz, et al.
Eclinicalmedicine|January 9, 2026
Abbreviated dual antiplatelet therapy after percutaneous coronary intervention with ultrathin-strut drug-eluting stents in South Korea: 3-year outcomes of the multicentre, randomised HOST-IDEA trialJung-Kyu Han, Doyeon Hwang, Seokhun Yang, et al.
Clinical Therapeutics|June 3, 2018
Efficacy and Safety of Ezetimibe and Rosuvastatin Combination Therapy Versus Those of Rosuvastatin Monotherapy in Patients With Primary HypercholesterolemiaWoohyeun Kim, Yeonyee E Yoon, Sung-Hee Shin, et al.
Hypertension (Dallas, Tex. : 1979)|February 20, 2026
Low-Dose TEL/AML/CHTD SPC Versus Standard-Dose TEL in Hypertension: Phase III RCTJeong Cheon Ahn, Cheol Whan Lee, Jong Hwa Ahn, et al.
Pageof 23

Showing results (191-200 of 222) with videos related to

Sort By:
Pageof 23
Clinical Hypertension|December 1, 2022
A randomized, double-blind, multicenter, phase III study on the efficacy and safety of a combination treatment involving fimasartan, amlodipine, rosuvastatin in patients with essential hypertension and dyslipidemia who fail to respond adequately to fimasartan monotherapyEun-Seok Jeon, Sang Wook Lim, Seok-Yeon Kim, et al.
Plos One|April 2, 2021
Smoking may be more harmful to vasospastic angina patients who take antiplatelet agents due to the interaction: Results of Korean prospective multi-center cohortSeong-Sik Cho, Sang-Ho Jo, Hyun-Jin Kim, et al.
Circulation. Cardiovascular Interventions|March 31, 2025
Short-Term DAPT After Complex PCI With Third-Generation DES: A Post Hoc Analysis of the HOST-IDEA TrialJung-Kyu Han, Keehwan Lee, Sang-Hyeon Park, et al.
Journal of the American Heart Association|March 29, 2022
Prognostic Impact of Chronic Vasodilator Therapy in Patients With Vasospastic AnginaYongwhan Lim, Min Chul Kim, Youngkeun Ahn, et al.
Journal of the American College of Cardiology|January 28, 2022
Clinical Outcomes in Patients With Delayed Hospitalization for Non-ST-Segment Elevation Myocardial InfarctionJung-Joon Cha, SungA Bae, Duk-Woo Park, et al.
Circulation|March 5, 2023
Comparison of 3- to 6-Month Versus 12-Month Dual Antiplatelet Therapy After Coronary Intervention Using the Contemporary Drug-Eluting Stents With Ultrathin Struts: The HOST-IDEA Randomized Clinical TrialJung-Kyu Han, Doyeon Hwang, Seokhun Yang, et al.
The American Journal of Cardiology|December 27, 2011
Relation of ruptured plaque culprit lesion phenotype and outcomes in patients with ST elevation acute myocardial infarctionSang Wook Kim, Young Joon Hong, Gary S Mintz, et al.
Eclinicalmedicine|January 9, 2026
Abbreviated dual antiplatelet therapy after percutaneous coronary intervention with ultrathin-strut drug-eluting stents in South Korea: 3-year outcomes of the multicentre, randomised HOST-IDEA trialJung-Kyu Han, Doyeon Hwang, Seokhun Yang, et al.
Clinical Therapeutics|June 3, 2018
Efficacy and Safety of Ezetimibe and Rosuvastatin Combination Therapy Versus Those of Rosuvastatin Monotherapy in Patients With Primary HypercholesterolemiaWoohyeun Kim, Yeonyee E Yoon, Sung-Hee Shin, et al.
Hypertension (Dallas, Tex. : 1979)|February 20, 2026
Low-Dose TEL/AML/CHTD SPC Versus Standard-Dose TEL in Hypertension: Phase III RCTJeong Cheon Ahn, Cheol Whan Lee, Jong Hwa Ahn, et al.
Pageof 23